DTL
TNGX icon

Dynamic Technology Lab’s Tango Therapeutics TNGX Stock Holding History

Dynamic Technology Lab’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,801
Closed -$35K – 1349
2025
Q1 		$35K Buy
25,801
+15,037
+140% +$36.9K 0.01% 940
2024
Q4 		$33K Buy
+10,764
New +$50K 0.01% 857
2024
Q1 		– Sell
-13,750
Closed -$136K – 1424
2023
Q4 		$136K Buy
+13,750
New +$119K 0.01% 926
2022
Q3 		– Sell
-19,594
Closed -$89K – 1529
2022
Q2 		$89K Buy
+19,594
New +$119K 0.01% 999

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Dynamic Technology Lab's TNGX Position: Q2 2025 in Review

Dynamic Technology Lab sold out of Tango Therapeutics (TNGX) in Q2 2025, closing a stake of 25,801 shares — an estimated $35K sold.

Dynamic Technology Lab first reported a position in TNGX in Q2 2022 and held it in 4 quarters. The position peaked at $136K in Q4 2023. 115 funds tracked by Wall St. Rank hold TNGX as of Q2 2025.

  • Dynamic Technology Lab reported no remaining Tango Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 25,801 Tango Therapeutics shares in Q2 2025, an estimated $35K.
  • Dynamic Technology Lab first reported a position in Tango Therapeutics in Q2 2022 and held it in 4 quarters.
  • Dynamic Technology Lab's Tango Therapeutics position peaked at $136K in Q4 2023.
  • 115 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2025.

Based on Dynamic Technology Lab's 13F filing for Q2 2025, filed 12 Aug 2025.